Clinical Trial Update: A Novel Drug for Borderline Personality Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of an undisclosed novel drug for Borderline Personality Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Undisclosed novel compound

Snippet

Sponsor: The Alfred | Conditions: Borderline Personality Disorder | Phase 2 | Status: RECRUITING